Answers are grounded in this paper and cite their sources.
Background: Complicated malaria occurs in 15–40% of hospitalised imported cases, and European centres often define it more broadly than the WHO 2023 severe-malaria criteria, which, calibrated for semi-immune populations, may under-identify severe disease in non-immune travellers; Central and Eastern European data are limited. We examined the clinical spectrum, travel destinations, and admission correlates of complicated imported malaria in non-immune Polish travellers. Methods: This was a two-centre, 11-year retrospective cohort of 93 laboratory-confirmed episodes in 91 adults (December 2014–October 2025). Complicated disease was a composite of organ-specific complications on admission. We derived the exploratory nine-item IMSC-NIT severity-capture criteria, with a pre-specified analysis restricted to the four items not overlapping the outcome (age, C-reactive protein, procalcitonin, platelets). Results: Complicated disease affected 31/93 episodes (33.3%), exceeding the 10/93 that met the strictly assessable WHO criteria. Plasmodium falciparum predominated; 88.2% with documented status had used no chemoprophylaxis; age was the only independently associated variable (multiple-imputation odds ratio 1.07 per year, 95% CI 1.02–1.11). The restricted four-item score gave an area under the curve of 0.76 (95% CI 0.65–0.85; optimism-corrected 0.72). Conclusions: The WHO criteria alone may miss non-immune travellers with organ involvement at presentation. The IMSC-NIT is a hypothesis-generating severity-capture aid requiring external validation before clinical use.
No takes yet. Share an insight, caveat, or question.
Pikor et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: